{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:30:11Z","timestamp":1785767411286,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaison committee between Helse Midt-Norge RHF and NTNU"},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["12\/ECF\/2-34"],"award-info":[{"award-number":["12\/ECF\/2-34"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["12\/ECF\/2-34"],"award-info":[{"award-number":["12\/ECF\/2-34"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["12\/ECF\/2-34"],"award-info":[{"award-number":["12\/ECF\/2-34"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary genetic mutations causing predisposition to colorectal cancer are accountable for approximately 30% of all colorectal cancer cases. However, only a small fraction of these are high penetrant mutations occurring in DNA mismatch repair genes, causing one of several types of familial colorectal cancer (CRC) syndromes. Most of the mutations are low-penetrant variants, contributing to an increased risk of familial colorectal cancer, and they are often found in additional genes and pathways not previously associated with CRC. The aim of this study was to identify such variants, both high-penetrant and low-penetrant ones.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed whole exome sequencing on constitutional DNA extracted from blood of 48 patients suspected of familial colorectal cancer and used multiple in silico prediction tools and available literature-based evidence to detect and investigate genetic variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified several causative and some potentially causative germline variants in genes known for their association with colorectal cancer. In addition, we identified several variants in genes not typically included in relevant gene panels for colorectal cancer, including<jats:italic>CFTR<\/jats:italic>,<jats:italic>PABPC1<\/jats:italic>and<jats:italic>TYRO3<\/jats:italic>, which may be associated with an increased risk for cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Identification of variants in additional genes that potentially can be associated with familial colorectal cancer indicates a larger genetic spectrum of this disease, not limited only to mismatch repair genes. Usage of multiple in silico tools based on different methods and combined through a consensus approach increases the sensitivity of predictions and narrows down a large list of variants to the ones that are most likely to be significant.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12920-023-01562-3","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T19:01:29Z","timestamp":1686337289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing"],"prefix":"10.1186","volume":"16","author":[{"given":"Ashish Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Talseth-Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Drabl\u00f8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenche","family":"Sjursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"issue":"16","key":"1562_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029\u201330.","journal-title":"Cancer"},{"key":"1562_CR2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"10","key":"1562_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41436-021-01207-9","volume":"23","author":"R Mao","year":"2021","unstructured":"Mao R, Krautscheid P, Graham RP, Ganguly A, Shankar S, Ferber M, et al. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(10):1807\u201317.","journal-title":"Genet Med."},{"key":"1562_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mam.2019.03.001","volume":"69","author":"L Valle","year":"2019","unstructured":"Valle L, de Voer RM, Goldberg Y, Sjursen W, F\u00f6rsti A, Ruiz-Ponte C, et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol Aspects Med. 2019;69:10\u201326.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"1562_CR5","first-page":"1","volume":"11","author":"C Fern\u00e1ndez-Rozadilla","year":"2021","unstructured":"Fern\u00e1ndez-Rozadilla C, \u00c1lvarez-Barona M, Quintana I, L\u00f3pez-Novo A, Amigo J, Cameselle-Teijeiro JM, et al. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer. Sci Reports. 2021;11(1):1\u20139.","journal-title":"Sci Reports."},{"issue":"5","key":"1562_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/path.5229","volume":"247","author":"L Valle","year":"2019","unstructured":"Valle L, Vilar E, Tavtigian SV, Stoffel EM. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol. 2019;247(5):574\u201388.","journal-title":"J Pathol"},{"issue":"6","key":"1562_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s13402-016-0284-6","volume":"39","author":"MM Hahn","year":"2016","unstructured":"Hahn MM, de Voer RM, Hoogerbrugge N, Ligtenberg MJL, Kuiper RP, van Kessel AG. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell Oncol. 2016;39(6):491\u2013510.","journal-title":"Cell Oncol."},{"issue":"1","key":"1562_CR8","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/s41598-022-06782-8","volume":"12","author":"FA de O Garcia","year":"2022","unstructured":"de O Garcia FA, de Andrade ES, de Campos Reis Galv\u00e3o H, da Silva S\u00e1bato C, Campacci N, de Paula AE, et al. New insights on familial colorectal cancer type X syndrome. Sci Rep. 2022;12(1):2846.","journal-title":"Sci Rep."},{"issue":"22","key":"1562_CR9","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.3390\/ijms21228757","volume":"21","author":"IBAW te Paske","year":"2020","unstructured":"te Paske IBAW, Ligtenberg MJL, Hoogerbrugge N, de Voer RM. Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future Studies. Int J Mol Sci. 2020;21(22):8757.","journal-title":"Int J Mol Sci."},{"key":"1562_CR10","doi-asserted-by":"crossref","unstructured":"Adam R, Spier I, Zhao B, Kloth M, Marquez J, Hinrichsen I, et al. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis. 2016;99(2):337\u201351.","DOI":"10.1016\/j.ajhg.2016.06.015"},{"issue":"6","key":"1562_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1053\/j.gastro.2017.03.013","volume":"152","author":"S Syngal","year":"2017","unstructured":"Q. Rana H, Syngal S. Biallelic Mismatch Repair Deficiency: Management and Prevention of a Devastating Manifestation of the Lynch Syndrome. Gastroenterology. 2017;152(6):1254\u20137.","journal-title":"Gastroenterology."},{"key":"1562_CR12","first-page":"1567","volume":"0","author":"K Fabi\u0161\u00edkov\u00e1","year":"2020","unstructured":"Fabi\u0161\u00edkov\u00e1 K, Hamidov\u00e1 O, Behulov\u00e1 RL, Z\u00e1vodn\u00e1 K, Pri\u0161\u010d\u00e1kov\u00e1 P, Repisk\u00e1 V. Case Report: The Role of Molecular Analysis of the MUTYH Gene in Asymptomatic Individuals. Front Genet. 2020;0:1567.","journal-title":"Front Genet."},{"issue":"1","key":"1562_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11(1):1\u20139.","journal-title":"Nat Commun"},{"issue":"7809","key":"1562_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nat. 2020;581(7809):434\u201343.","journal-title":"Nat."},{"issue":"1","key":"1562_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2164-13-194","volume":"13","author":"Y Guo","year":"2012","unstructured":"Guo Y, Long J, He J, Li C-I, Cai Q, Shu X-O, et al. Exome sequencing generates high quality data in non-target regions. BMC Genomics. 2012;13(1):194.","journal-title":"BMC Genomics"},{"issue":"5","key":"1562_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/bfgp\/elv054","volume":"15","author":"EG Seaby","year":"2016","unstructured":"Seaby EG, Pengelly RJ, Ennis S. Exome sequencing explained: a practical guide to its clinical application. Brief Funct Genomics. 2016;15(5):374\u201384.","journal-title":"Brief Funct Genomics"},{"issue":"1","key":"1562_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13059-019-1828-7","volume":"20","author":"M Mahmoud","year":"2019","unstructured":"Mahmoud M, Gobet N, Cruz-D\u00e1valos DI, Mounier N, Dessimoz C, Sedlazeck FJ. Structural variant calling: the long and the short of it. Genome Biol. 2019;20(1):246.","journal-title":"Genome Biol"},{"issue":"4","key":"1562_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrg.2015.25","volume":"17","author":"CMB Carvalho","year":"2016","unstructured":"Carvalho CMB, Lupski JR. Mechanisms underlying structural variant formation in genomic disorders. Nat Rev Genet. 2016;17(4):224\u201338.","journal-title":"Nat Rev Genet"},{"key":"1562_CR19","doi-asserted-by":"crossref","unstructured":"Moreno-Cabrera JM, del Valle J, Castellanos E, Feliubadal\u00f3 L, Pineda M, Brunet J, et al. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics. Eur J Hum Genet. 2020;28(12)1645\u201355.","DOI":"10.1038\/s41431-020-0675-z"},{"key":"1562_CR20","doi-asserted-by":"crossref","unstructured":"Gabrielaite M, Torp MH, Rasmussen MS, Andreu-S\u00e1nchez S, Vieira FG, Pedersen CB, et al. A comparison of tools for copy-number variation detection in germline whole exome and whole genome sequencing data. Cancers. 2021;13(24):6283.","DOI":"10.3390\/cancers13246283"},{"key":"1562_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mam.2019.07.007","volume":"69","author":"T Ried","year":"2019","unstructured":"Ried T, Meijer GA, Harrison DJ, Grech G, Franch-Exp\u00f3sito S, Briffa R, et al. The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome. Mol Aspects Med. 2019;69:48\u201361.","journal-title":"Mol Aspects Med"},{"issue":"1110","key":"1562_CR22","first-page":"11.10.1-11.10.3","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, del Angel G, Levy-Moonshine A, et al. From fastQ data to high-confidence variant calls: The genome analysis toolkit best practices pipeline. Curr Protoc Bioinforma. 2013;43(1110):11.10.1-11.10.33.","journal-title":"Curr Protoc Bioinforma."},{"issue":"1","key":"1562_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmoldx.2019.08.009","volume":"22","author":"S V\u00e4lipakka","year":"2020","unstructured":"V\u00e4lipakka S, Savarese M, Sagath L, Arumilli M, Giugliano T, Udd B, et al. Improving Copy Number Variant Detection from Sequencing Data with a Combination of Programs and a Predictive Model. J Mol Diagnostics. 2020;22(1):40\u20139.","journal-title":"J Mol Diagnostics"},{"issue":"1","key":"1562_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"issue":"16","key":"1562_CR25","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164\u2013e164.","journal-title":"Nucleic Acids Res"},{"key":"1562_CR26","doi-asserted-by":"crossref","unstructured":"Vermeer MCSC, Andrei D, Marsili L, van Tintelen JP, Sillj\u00e9 HHW, van den Berg MP, et al. Towards a better understanding of genotype-phenotype correlations and therapeutic targets for cardiocutaneous genes: the importance of functional studies above prediction. Int J Mol Sci. 2022;23(18):10765.","DOI":"10.3390\/ijms231810765"},{"issue":"1","key":"1562_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","volume":"14","author":"S Marwaha","year":"2022","unstructured":"Marwaha S, Knowles JW, Ashley EA. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 2022;14(1):23.","journal-title":"Genome Med"},{"issue":"8","key":"1562_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/humu.21517","volume":"32","author":"X Liu","year":"2011","unstructured":"Liu X, Jian X, Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat. 2011;32(8):894\u20139.","journal-title":"Hum Mutat"},{"issue":"1","key":"1562_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X, Li C, Mou C, Dong Y, Tu Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 2020;12(1):103.","journal-title":"Genome Med"},{"issue":"1","key":"1562_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12920-021-01059-x","volume":"14","author":"AK Singh","year":"2021","unstructured":"Singh AK, Olsen MF, Lavik LAS, Vold T, Drabl\u00f8s F, Sjursen W. Detecting copy number variation in next generation sequencing data from diagnostic gene panels. BMC Med Genomics. 2021;14(1):214.","journal-title":"BMC Med Genomics"},{"issue":"D1","key":"1562_CR31","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1562_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"issue":"D1","key":"1562_CR33","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1562_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajhg.2018.08.005","volume":"103","author":"N Alirezaie","year":"2018","unstructured":"Alirezaie N, Kernohan KD, Hartley T, Majewski J, Hocking TD. ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants. Am J Hum Genet. 2018;103(4):474\u201383.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1562_CR35","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/ng.3703","volume":"48","author":"KA Jagadeesh","year":"2016","unstructured":"Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48(12):1581\u20136.","journal-title":"Nat Genet"},{"issue":"D1","key":"1562_CR36","doi-asserted-by":"publisher","first-page":"D297","DOI":"10.1093\/nar\/gkt1208","volume":"42","author":"T Madej","year":"2014","unstructured":"Madej T, Lanczycki CJ, Zhang D, Thiessen PA, Geer RC, Marchler-Bauer A, et al. MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic Acids Res. 2014;42(D1):D297-303.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1562_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13040-017-0126-8","volume":"10","author":"S Kim","year":"2017","unstructured":"Kim S, Jhong J-H, Lee J, Koo J-Y. Meta-analytic support vector machine for integrating multiple omics data. BioData Min. 2017;10(1):2.","journal-title":"BioData Min"},{"issue":"3","key":"1562_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/humu.23158","volume":"38","author":"B-J Feng","year":"2017","unstructured":"Feng B-J. PERCH: A Unified Framework for Disease Gene Prioritization. Hum Mutat. 2017;38(3):243\u201351.","journal-title":"Hum Mutat"},{"issue":"3","key":"1562_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176(3):535-548.e24.","journal-title":"Cell"},{"key":"1562_CR40","doi-asserted-by":"crossref","unstructured":"Anderson D, Lassmann T. An expanded phenotype centric benchmark of variant prioritisation tools. Hum Mutat. 2022;43(5):539\u201346.","DOI":"10.1002\/humu.24362"},{"key":"1562_CR41","doi-asserted-by":"crossref","unstructured":"Borges P, Pasqualim G, Matte U. Which is the best in silico program for the missense variations in IDUA gene? a comparison of 33 programs plus a conservation score and evaluation of 586 missense variants. Front Mol Biosci. 2021;8:752797.","DOI":"10.3389\/fmolb.2021.752797"},{"issue":"8","key":"1562_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/jmedgenet-2020-107003","volume":"58","author":"AC Gunning","year":"2021","unstructured":"Gunning AC, Fryer V, Fasham J, Crosby AH, Ellard S, Baple EL, et al. Assessing performance of pathogenicity predictors using clinically relevant variant datasets. J Med Genet. 2021;58(8):547\u201355.","journal-title":"J Med Genet."},{"issue":"D1","key":"1562_CR43","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019;47(D1):D941\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1562_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","volume":"1","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty D, Gao J, Phillips S, Kundra R, Zhang H, Wang J, et al. OncoKB: A Precision Oncology Knowledge Base. JCO Precis Oncol. 2017;1:1\u201316.","journal-title":"JCO Precis Oncol"},{"issue":"D1","key":"1562_CR45","doi-asserted-by":"publisher","first-page":"D1023","DOI":"10.1093\/nar\/gkv1268","volume":"44","author":"M Zhao","year":"2016","unstructured":"Zhao M, Kim P, Mitra R, Zhao J, Zhao Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 2016;44(D1):D1023-31.","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"1562_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations. Gastroenterology. 2008;135(2):419-428.e1.","journal-title":"Gastroenterology"},{"issue":"11","key":"1562_CR47","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/humu.22426","volume":"34","author":"M Drost","year":"2013","unstructured":"Drost M, Koppejan H, de Wind N. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene. Hum Mutat. 2013;34(11):1477\u201380.","journal-title":"Hum Mutat"},{"key":"1562_CR48","first-page":"8657823","volume":"2018","author":"A Hildreth","year":"2018","unstructured":"Hildreth A, Valasek MA, Thung I, Savides T, Sivagnanam M, Ramamoorthy S, et al. Biallelic Mismatch Repair Deficiency in an Adolescent Female. Yapijakis C, editor. Case Rep Genet. 2018;2018:8657823.","journal-title":"Case Rep Genet."},{"issue":"4","key":"1562_CR49","first-page":"491","volume":"10","author":"D Ramos","year":"2022","unstructured":"Ramos D, Brand\u00e3o C, Sousa C, Dinis-Ribeiro M. Biallelic mismatch repair deficiency: A rare and trouble genetic syndrome. J Neurol Disord. 2022;10(4):491.","journal-title":"J Neurol Disord"},{"issue":"3","key":"1562_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10689-008-9225-5","volume":"8","author":"W Sjursen","year":"2009","unstructured":"Sjursen W, Bj\u00f8rnevoll I, Engebretsen LF, Fjelland K, Halvorsen T, Myrvold HE. A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts. Fam Cancer. 2009;8(3):179\u201386.","journal-title":"Fam Cancer"},{"issue":"2","key":"1562_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1210\/jc.2017-01762","volume":"103","author":"K van der Tuin","year":"2018","unstructured":"van der Tuin K, Mensenkamp AR, Tops CMJ, Corssmit EPM, Dinjens WN, van de Horst-Schrivers AN, et al. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study. J Clin Endocrinol Metab. 2018;103(2):438\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1562_CR52","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/bjs.11603","volume":"107","author":"CM Cullinane","year":"2020","unstructured":"Cullinane CM, Creavin B, O\u2019Connell EP, Kelly L, O\u2019Sullivan MJ, Corrigan MA, et al. Risk of colorectal cancer associated with BRCA1 and\/or BRCA2 mutation carriers: systematic review and meta-analysis. Br J Surg. 2020;107(8):951\u20139.","journal-title":"Br J Surg"},{"key":"1562_CR53","doi-asserted-by":"crossref","unstructured":"Scott P, Anderson K, Singhania M, Cormier R. Cystic fibrosis, CFTR, and colorectal cancer. Int J Mol Sci. 2020;21(8):2891.","DOI":"10.3390\/ijms21082891"},{"issue":"38","key":"1562_CR54","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.3748\/wjg.v25.i38.5732","volume":"25","author":"KJ Anderson","year":"2019","unstructured":"Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol. 2019;25(38):5732\u201372.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1562_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbaexp.2004.03.008","volume":"1678","author":"U K\u00fchn","year":"2004","unstructured":"K\u00fchn U, Wahle E. Structure and function of poly(A) binding proteins. Biochim Biophys Acta - Gene Struct Expr. 2004;1678(2):67\u201384.","journal-title":"Biochim Biophys Acta - Gene Struct Expr"},{"issue":"4","key":"1562_CR56","first-page":"3794","volume":"8","author":"J Zhu","year":"2015","unstructured":"Zhu J, Ding H, Wang X, Lu Q. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c. Int J Clin Exp Pathol. 2015;8(4):3794\u2013802.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1562_CR57","first-page":"667","volume":"15","author":"N Takashima","year":"2006","unstructured":"Takashima N, Ishiguro H, Kuwabara Y, Kimura M, Haruki N, Ando T, et al. Expression and prognostic roles of PABPC1 in esophageal cancer: Correlation with tumor progression and postoperative survival. Oncol Rep. 2006;15(3):667\u201371.","journal-title":"Oncol Rep"},{"issue":"8","key":"1562_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s13258-022-01275-4","volume":"44","author":"SA Jeon","year":"2022","unstructured":"Jeon SA, Ha YJ, Kim J-H, Kim J-H, Kim S-K, Kim YS, et al. Genomic and transcriptomic analysis of Korean colorectal cancer patients. Genes Genomics. 2022;44(8):967\u201379.","journal-title":"Genes Genomics"},{"key":"1562_CR59","doi-asserted-by":"crossref","unstructured":"Smart SK, Vasileiadi E, Wang X, DeRyckere D, Graham DK. The emerging role of TYRO3 as a therapeutic target in cancer. Cancers. 2018;10(12):474.","DOI":"10.3390\/cancers10120474"},{"key":"1562_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2021.101111","volume":"28","author":"N Al Kafri","year":"2021","unstructured":"Al Kafri N, Hafizi S. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells. Biochem Biophys Reports. 2021;28:101111.","journal-title":"Biochem Biophys Reports"},{"issue":"1","key":"1562_CR61","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12935-020-01519-x","volume":"20","author":"J Du","year":"2020","unstructured":"Du J, Xu J, Chen J, Liu W, Wang P, Ye K. circRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338-3p\/TYRO3 axis. Cancer Cell Int. 2020;20(1):430.","journal-title":"Cancer Cell Int"},{"key":"1562_CR62","doi-asserted-by":"crossref","unstructured":"Huang Y, Chen Z, Zhou X, Huang H. Circ_0000467 exerts an oncogenic role in colorectal cancer via miR-330\u20135p-dependent regulation of TYRO3. Biochem Genet. 2022;60(5):1488\u2013510.","DOI":"10.1007\/s10528-021-10171-7"},{"issue":"10","key":"1562_CR63","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1038\/cddis.2012.142","volume":"3","author":"TJ Collard","year":"2012","unstructured":"Collard TJ, Urban BC, Patsos HA, Hague A, Townsend PA, Paraskeva C, et al. The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells. Cell Death Dis. 2012;3(10):e408\u2013e408.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1562_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41525-021-00227-3","volume":"6","author":"BS Pedersen","year":"2021","unstructured":"Pedersen BS, Brown JM, Dashnow H, Wallace AD, Velinder M, Tristani-Firouzi M, et al. Effective variant filtering and expected candidate variant yield in studies of rare human disease. npj Genomic Med. 2021;6(1):60.","journal-title":"npj Genomic Med."},{"issue":"6","key":"1562_CR65","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/mgg3.498","volume":"6","author":"DM Gianferante","year":"2018","unstructured":"Gianferante DM, Rotunno M, Dean M, Zhou W, Hicks BD, Wyatt K, et al. Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data. Mol Genet Genomic Med. 2018;6(6):1168\u201380.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"1562_CR66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1562_CR67","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1038\/s41598-021-85182-w","volume":"11","author":"A Arteche-L\u00f3pez","year":"2021","unstructured":"Arteche-L\u00f3pez A, \u00c1vila-Fern\u00e1ndez A, Romero R, Riveiro-\u00c1lvarez R, L\u00f3pez-Mart\u00ednez MA, Gim\u00e9nez-Pardo A, et al. Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes. Sci Rep. 2021;11(1):5697.","journal-title":"Sci Rep"},{"key":"1562_CR68","unstructured":"AlamutTM Visual Plus version 1.6.1 [Internet]. SOPHiA GENETICSTM.\u00a0https:\/\/www.sophiagenetics.com\/platform\/alamut-visual-plus\/."},{"issue":"5","key":"1562_CR69","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrc2840","volume":"10","author":"O Fletcher","year":"2010","unstructured":"Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer. 2010;10(5):353\u201361.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1562_CR70","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jnci\/djy099","volume":"111","author":"SL Schmit","year":"2019","unstructured":"Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, et al. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. JNCI J Natl Cancer Inst. 2019;111(2):146\u201357.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"1562_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12885-021-09143-2","volume":"22","author":"M Sassano","year":"2022","unstructured":"Sassano M, Mariani M, Quaranta G, Pastorino R, Boccia S. Polygenic risk prediction models for colorectal cancer: a systematic review. BMC Cancer. 2022;22(1):65.","journal-title":"BMC Cancer"},{"issue":"7","key":"1562_CR72","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41388-020-01614-3","volume":"40","author":"H Jung","year":"2021","unstructured":"Jung H, Lee KS, Choi JK. Comprehensive characterisation of intronic mis-splicing mutations in human cancers. Oncogene. 2021;40(7):1347\u201361.","journal-title":"Oncogene"},{"issue":"8","key":"1562_CR73","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/bioinformatics\/btaa783","volume":"37","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wakeling M, Ware J, Whiffin N. Annotating high-impact 5\u2032untranslated region variants with the UTRannotator. Bioinformatics. 2021;37(8):1171\u20133.","journal-title":"Bioinformatics"},{"issue":"3","key":"1562_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/mutage\/gez027","volume":"35","author":"SA Schubert","year":"2020","unstructured":"Schubert SA, Morreau H, de Miranda NFCC, van Wezel T. The missing heritability of familial colorectal cancer. Mutagenesis. 2020;35(3):221\u201331.","journal-title":"Mutagenesis"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01562-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T01:41:45Z","timestamp":1729561305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01562-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1562"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01562-3","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the Helsinki Declaration and approved by the Hunter New England Human Research Ethics Committee, Australia (04\/03\/10\/3.11) and Regional Ethics Committee (REK), Norway (2015\/838). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}